TOP - Daily

The FDA recently approved abiraterone acetate, a drug that decreases the production of testosterone, for use in treating men with metastatic castration-resistant prostate cancer prior to receiving chemotherapy. Read More ›

The question of potential overtreatment among women with breast cancer has been raised due to recent studies showing an increase in these patients choosing the more aggressive contralateral prophylactic mastectomy. Read More ›

By adding tomosynthesis, a 3-dimensional (3-D) breast imaging technology, to standard digital mammography, radiologists’ diagnostic accuracy increases while false-positive recall rates decrease Read More ›

New study findings related to the drug metformin may aid researchers as they study the use of existing medications to treat different or new diseases. Read More ›

National investment in clinical cancer research on prevention, screening, survival, and quality of life for patients with cancer is reflected in the large number of advances featured in this year’s report. Read More ›

For patients with prostate cancer that had spread to the bone, a new drug exhibited remarkable and quick effects. Read More ›

Each year, physicians discontinue more than 85,000 medications; however, this information is not always shared with the pharmacists involved. Read More ›

Results from a new study show that when compared with beginning therapy shortly after diagnosis, women who wait more than 60 days to begin treatment for advanced breast cancer face significantly higher risks of dying. Read More ›

Many patients and their loved ones find it difficult to discuss end-of-life care with physicians. Read More ›

A new study shows that chemotherapy can induce changes in the brain that may affect concentration and memory. Read More ›